Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-06-26 @ 4:33 AM
Study NCT ID:
NCT00037102
Status:
COMPLETED
Last Update Posted:
2018-04-12
First Post:
2002-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
Sponsor:
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MANI-MTX01-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None